Excludes an aggregate of up to 750,000 Class B ordinary shares subject to forfeiture by the holders thereof depending on the extent to which the underwriters’ over-allotment option was exercised (Note 5). On February 4, 2026, the Company consummated its Initial Public Offering and sold 16,850,000 Units, including 1,850,000 Units sold pursuant to the partial exercise of the underwriters’ option to purchase additional units to cover the over-allotment, hence the 616,667 shares of Class B ordinary shares were no longer subject to forfeiture and 133,333 have been forfeited.

CONDENSED STATEMENT OF CASH FLOWS - USD ($)	6 Months Ended
CONDENSED STATEMENT OF CASH FLOWS - USD ($)	Jun. 30, 2026
Cash Flows from Operating Activities:
Net income	$ 2,037,510
Adjustments to reconcile net income to net cash used in operating activities:
Interest earned on cash held in Trust Account	(2,442,950)
Payment of general and administrative costs through promissory note – related party	49,743
Changes in operating assets and liabilities:
Prepaid expenses and insurance	4,776
Long-term prepaid insurance	26,930
Accounts payable and accrued expenses	159,713
Accrued interest on short-term loan	367
Net cash used in operating activities	(163,911)
Cash Flows from Investing Activities:
Cash held in Trust Account	(168,500,000)
Net cash used in investing activities	(168,500,000)
Cash Flows from Financing Activities:
Proceeds from sale of Units, net of underwriting discounts paid	165,505,000
Proceeds from sale of Private Placement Units	4,380,000
Proceeds from subscription receivable	21,960
Repayments of short-term loan	(70,221)
Repayment of promissory note – related party	(421,500)
Payment of offering costs	(51,755)
Net cash provided by financing activities	169,363,484
Net Change in Cash	699,573
Cash – Beginning of period	0
Cash – End of period	699,573
Supplementary cash flow information:
Cash paid for interest on short-term loan	1,536
Non-Cash investing and financing activities:
Forfeiture of Founder Shares	13
Offering costs included in offering costs payable	49,051
Deferred offering costs paid through promissory note – related party	262,640
Prepaid services contributed by Sponsor through promissory note - related party	11,351
Prepaid insurance funded through short-term loan	133,059
Accretion of Class A ordinary shares to redemption value	17,841,821
Offering cost included in equity	334,888
Deferred underwriting fee payable	$ 7,115,000

CONDENSED BALANCE SHEETS - USD ($)

Jun. 30, 2026

Dec. 31, 2025

ASSETS

Cash

$ 699,573

$ 0

Prepaid expense and insurance

73,105

Total Current Assets

772,678

Deferred offering costs

139,598

Long-term prepaid insurance

39,601

Cash held in Trust Account

170,942,950

TOTAL ASSETS

171,755,229

139,598

Current Liabilities

Accounts payable and accrued expenses

183,305

23,592

Offering costs payable

132,274

83,223

Short-term loan

63,207

Total Current Liabilities

378,786

182,621

Deferred underwriting fee payable

7,115,000

Total Liabilities

7,493,786

182,621

Commitments and Contingencies (Note 5)

Shareholders’ Deficit

Preference shares, $0.0001 par value; 1,000,000 shares authorized; no shares issued or outstanding as of June 30, 2026 and December 31, 2025, respectively

Additional paid-in capital

24,425

Accumulated deficit

(6,682,113)

(68,023)

Total Shareholders’ Deficit

(6,681,507)

(43,023)

TOTAL LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS’ DEFICIT

171,755,229

139,598

Related Party

Current Liabilities

Promissory note - related party

75,806

Class A Ordinary Shares Subject To Redemption

Current Liabilities

Class A ordinary shares subject to possible redemption, $0.0001 par value; 16,850,000 and no shares at a redemption value of $10.14 and $0 per share as of June 30, 2026 and December 31, 2025, respectively

170,942,950

Class A Ordinary Shares

Shareholders’ Deficit

Common stock value

Class B Ordinary Shares

Shareholders’ Deficit

Common stock value

^[1]

$ 562

$ 575

[1]

Includes an aggregate of up to 750,000 Class B ordinary shares subject to forfeiture by the holders thereof depending on the extent to which the underwriters’ over-allotment option was exercised (Note 5). On February 4, 2026, the Company consummated its Initial Public Offering and sold 16,850,000 Units, including 1,850,000 Units sold pursuant to the partial exercise of the underwriters’ option to purchase additional units to cover the over-allotment, hence the 616,667 shares of Class B ordinary shares were no longer subject to forfeiture and 133,333 have been forfeited.